Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Functional diversification of CsCAD14 orchestrates synergistic phenylpropanoid biosynthesis to defend gray blight disease in tea plants.

Created on 01 Oct 2026

Authors

Linlin Xu, Songyan Huang, Jie Deng, Chunmiao Zhang, Jing Yang, Mengsha Tang, Lingyao Luo, Hongrong Chen, Shengrui Liu, De-Yu Xie, Zuojia Zhang, Chaoling Wei, Junyan Zhu

Published in

Science advances. Volume 12. Issue 40. Pages eaei1647. Oct 02, 2026. Epub Sep 30, 2026.

Abstract

Phenylpropanoid metabolism is a crucial secondary metabolic pathway in plants. Numerous neofunctionalized and specialized enzymes emerged during plant terrestrialization, yielding metabolites contributing to environmental adaptation. Here, a cinnamyl alcohol dehydrogenase from tea plant (Camellia sinensis), CsCAD14, exhibited dual activity catalyzing monolignol and hydroxycinnamic acid biosynthesis. Antifungal assays showed that monolignols and hydroxycinnamic acids synergistically inhibited Pestalotiopsis growth. Integrated functional characterizations revealed that CsCAD14 enhanced gray blight disease resistance by increasing monolignol and hydroxycinnamic acid levels compared to CsCAD11 featured with single-enzymatic activity. Notably, genetic analysis of F1 progeny from crossing susceptible and resistant tea cultivars identified a nonsynonymous mutation in the CsCAD14 coding region, which abolished dual-enzymatic activity and was associated with pathogen susceptibility. Furthermore, evolutionary analysis revealed a positively selected amino acid substitution (L192V) driving CAD functional diversification from single-enzymatic activity in algae to dual-enzymatic activity in land plants. These findings uncover neofunctionalization of dual-activity CADs evolved for phenylpropanoid defense to enhance fungal disease resistance during plant adaptation to terrestrial environments.

PMID:
42814828
Bibliographic data and abstract were imported from PubMed on 01 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 17
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement